tiprankstipranks
Lyell Immunopharma (LYEL)
NASDAQ:LYEL
US Market
Holding LYEL?
Track your performance easily

Lyell Immunopharma (LYEL) Balance Sheet

92 Followers

Lyell Immunopharma Balance Sheet

Lyell Immunopharma's total assets for Q3 2024 were $619.22M, a decrease of -5.34% from the previous quarter. LYEL total liabilities were $88.52M for the fiscal quarter, a 1.00% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 750.03M$ 937.56M$ 1.13B$ 908.28M$ 555.63M
Total Liabilities
$ 95.08M$ 104.31M$ 197.62M$ 189.84M$ 147.58M
Total Equity Gross Minority
$ 654.95M$ 833.25M$ 929.79M$ 718.44M$ 408.06M
Total Capitalization
$ 711.85M$ 896.42M$ 996.44M$ 718.44M$ 408.06M
Preferred Stock Equity
---$ 1.01B$ 519.16M
Capital Lease Obligations
---$ 54.57M$ 27.47M
Currency in USD

Lyell Immunopharma Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis